Matinas BioPharma Holdings Inc (MTNB) earnings · $5.6M cap
These earnings events as JSON? API free 100/dayMatinas BioPharma Holdings Inc (MTNB) is a biotechnology company listed on US.
This MTNB earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MTNB revenue for 2023-09-30 was $1.1M. Net income was -$6.1M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. MTNB currently screens at market cap $5.6M.
When the next MTNB 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 0.0% from 2023-06-30 to 2023-09-30. An earnings headline that ignores that move is noise.
Not investment advice. Full MTNB research stays on the stock page; the tape stays on the quote page.
MTNB earnings FAQ
What are MTNB's latest revenue and net income?
Latest cached Matinas BioPharma Holdings Inc (MTNB) revenue for Sep 30, 2023 was $1.1M. Net income was -$6.1M. Statements: https://lician.com/financials/mtnb
What period does the latest MTNB earnings print cover?
The latest cached Matinas BioPharma Holdings Inc (MTNB) earnings print covers Sep 30, 2023. The prior cached period on this page is Jun 30, 2023.
How did MTNB revenue change from the prior cached period?
Cached Matinas BioPharma Holdings Inc (MTNB) revenue was unchanged from $1.1M (Jun 30, 2023) to $1.1M (Sep 30, 2023). Statements: https://lician.com/financials/mtnb
Where are MTNB earnings listed?
Cached earnings facts for Matinas BioPharma Holdings Inc (MTNB) are listed at https://lician.com/earnings/mtnb. Statements: https://lician.com/financials/mtnb
Not investment advice.